Related Experiment Video
Updated: Apr 18, 2026

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
Erratum to: Negative feedback of miR-29 family TET1 involves in hepatocellular cancer
Li Li Lin1, Wei Wang, ZhaoYang Hu
1Department of Pharmacology, Wuxi Higher Health Vocational Technology School, No. 305, Xinguang Road, Wuxi, 214028, China.
Abstract:
Primary hepatocellular carcinoma (HCC) is the most common form of liver cancer and is one of the most common malignancies worldwide. Tumor suppressor gene silencing through DNA methylation contributes to cancer formation. The ten-eleven translocations (TET) family of α-ketogluta-rate-dependent dioxygenases catalyzes the sequential oxidation of 5-methylcytosine to 5-hydroxymethyl-cytosine, 5-formylcytosine and 5-carboxylcytosine, leading to eventual DNA demethylation. MicroRNAs are an abundant class of 17-25 nucleotides small noncoding RNAs, identified as important regulators of many diverse biological processes. In this study, we showed that TET1 expression was obviously reduced in the majority of examined HCC tissues. And we further investigated the expression and functional involvement of TET1 in proliferation, migration and invasion and determined that TET1 may function as a tumor suppressor. miR-29b was proved to inhibit metastasis through the targeting of TET1, indicating that downregulation of miR-29 may involve in HCC carcinogenesis and progression through potentiation of TET1 expression. Thus, we elucidated the roles of feedback of miR-29-TET1 downregulation in HCC development and suggested a potential target in identification of the prognosis and application of cancer therapy for HCC patients.
Insights
TET1, a tumor suppressor, is reduced in hepatocellular carcinoma (HCC). Downregulation of miR-29 potentiates TET1, suggesting a feedback loop in HCC development and potential therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Primary hepatocellular carcinoma (HCC) is a prevalent malignancy worldwide.
- Tumor suppressor gene silencing via DNA methylation is a key mechanism in cancer development.
- The ten-eleven translocation (TET) family enzymes are crucial for DNA demethylation.
Purpose of the Study:
- To investigate the expression and function of TET1 in HCC.
- To explore the role of miR-29b in regulating TET1 and its impact on HCC progression.
- To elucidate the feedback mechanism between miR-29 and TET1 in HCC development.
Main Methods:
- Analysis of TET1 expression in HCC tissues.
- Functional assays assessing TET1's role in HCC cell proliferation, migration, and invasion.
- Investigation of miR-29b's regulatory effect on TET1 and its implications in HCC.
Main Results:
- TET1 expression was significantly reduced in most HCC tissues examined.
- TET1 demonstrated tumor suppressor activity by inhibiting HCC cell proliferation, migration, and invasion.
- miR-29b was identified as an inhibitor of metastasis by targeting TET1, suggesting miR-29 downregulation potentiates TET1 expression in HCC.
Conclusions:
- TET1 functions as a tumor suppressor in hepatocellular carcinoma.
- The miR-29/TET1 axis represents a critical feedback loop in HCC development and progression.
- Targeting the miR-29-TET1 pathway offers potential for HCC prognosis and therapeutic strategies.
More Related Videos
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

